Showing results (2671-2680 of 3,836) with videos related to
Sort By:
Pageof 384
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.Cancer Cell|May 5, 2023
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general populationIsabelle A van Zeventer, Aniek O de Graaf, Jonas B Salzbrunn, et al.Cancer Cell|April 28, 2023
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulatorsAleksandar Obradovic, Casey Ager, Mikko Turunen, et al.Cancer Cell|May 19, 2023
Hot on the trail in the TME: Clues from a trilogy of checkpoint inhibitor trials in nasopharyngeal cancerBrigette B Y Ma, Quynh Thu LeCancer Cell|May 19, 2023
Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinomaAlexandra Lahtinen, Kari Lavikka, Anni Virtanen, et al.Cancer Cell|May 19, 2023
Calreticulin exposure orchestrates innate immunosurveillanceEmma Guilbaud, Guido Kroemer, Lorenzo GalluzziCancer Cell|February 3, 2015
Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesisPatrick A Carroll, Daniel Diolaiti, Lisa McFerrin, et al.Cancer Cell|July 2, 2014
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathwayDirena Alonso-Curbelo, Erica Riveiro-Falkenbach, Eva Pérez-Guijarro, et al.Cancer Cell|June 27, 2020
PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer ProgressionYotaro Kudo, Masayuki Sugimoto, Esperanza Arias, et al.Cancer Cell|October 20, 2012
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomasXinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.Pageof 384